tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GSK reports EMA accepts marketing authoriaation application for Blenrep combos
The FlyGSK reports EMA accepts marketing authoriaation application for Blenrep combos
3d ago
GSK
GSK’s Blenrep Sets Sights on Transforming Myeloma Treatment
PremiumCompany Announcements
GSK’s Blenrep Sets Sights on Transforming Myeloma Treatment
3d ago
GSK Executives Invest in Company Shares
PremiumCompany Announcements
GSK Executives Invest in Company Shares
4d ago
GSK Executives Reinforce Commitment via Share Investment
PremiumCompany Announcements
GSK Executives Reinforce Commitment via Share Investment
6d ago
GSK Executives Boost Shareholdings Through Dividends
PremiumCompany Announcements
GSK Executives Boost Shareholdings Through Dividends
7d ago
GSK Leaders Invest in Company’s Future
PremiumCompany AnnouncementsGSK Leaders Invest in Company’s Future
10d ago
GSK Pharma call volume above normal and directionally bullish
PremiumThe Fly
GSK Pharma call volume above normal and directionally bullish
11d ago
GSK
GSK begins shipping influenza vaccine doses for 2024-25 season
PremiumThe Fly
GSK begins shipping influenza vaccine doses for 2024-25 season
11d ago
GSK
GSK begins shipping doses of its trivalent influenza vaccines in U.S.
PremiumThe Fly
GSK begins shipping doses of its trivalent influenza vaccines in U.S.
11d ago
GSK
GSK price target lowered to 1,922 GBp from 2,092 GBp at Guggenheim
PremiumThe Fly
GSK price target lowered to 1,922 GBp from 2,092 GBp at Guggenheim
11d ago
GSK
GSK Pharma put volume heavy and directionally bearish
PremiumThe Fly
GSK Pharma put volume heavy and directionally bearish
14d ago
GSK
iTeos Therapeutics announces first patient dosed in GALAXIES Lung-301 study
PremiumThe Fly
iTeos Therapeutics announces first patient dosed in GALAXIES Lung-301 study
14d ago
GSK
ITOS
GSK downgraded to Neutral from Buy at UBS
PremiumThe FlyGSK downgraded to Neutral from Buy at UBS
14d ago
GSK
FDA to evaluate potential risk of neural tube birth defects with dolutegravir
PremiumThe Fly
FDA to evaluate potential risk of neural tube birth defects with dolutegravir
17d ago
GSK
PFE
GSK Acquires Key Vaccine Rights from Partner CureVac in €1.45B Deal
PremiumMarket News
GSK Acquires Key Vaccine Rights from Partner CureVac in €1.45B Deal
19d ago
GSK
CVAC
CureVac jumps 21% to $4.06 after GSK expands licensing deal
PremiumThe Fly
CureVac jumps 21% to $4.06 after GSK expands licensing deal
19d ago
GSK
CVAC
GSK, CureVac restructure existing collaboration into new licensing agreement
PremiumThe Fly
GSK, CureVac restructure existing collaboration into new licensing agreement
19d ago
GSK
CVAC
GSK price target raised to $53 from $52.50 at Jefferies
PremiumThe Fly
GSK price target raised to $53 from $52.50 at Jefferies
20d ago
GSK
GSK Pharma call volume above normal and directionally bullish
PremiumThe Fly
GSK Pharma call volume above normal and directionally bullish
21d ago
GSK
GSK Updates Market on Share Capital and Voting Rights
PremiumCompany AnnouncementsGSK Updates Market on Share Capital and Voting Rights
21d ago
GSK Pharma call volume above normal and directionally bullish
PremiumThe Fly
GSK Pharma call volume above normal and directionally bullish
24d ago
GSK
GSK Settles Lawsuit, Continues Vigorous Defense
PremiumCompany Announcements
GSK Settles Lawsuit, Continues Vigorous Defense
24d ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >